Clinical Trial Update: Lanreotide Autogel in the Symptomatic Treatment of Refractory Diarrhea [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for lanreotide Autogel evaluating symptomatic treatment of refractory diarrhea across phase 2 and phase 3; results posted after completi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea

Drugs mentioned

• Lanreotide Autogel (lanreotide)

Snippet

Sponsor: Ipsen | Conditions: Diarrhea | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-09-29